Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study

Author:

Waldock Joanna1,Zheng Lingyi2,Remarque Edmond J.3,Civet Alexandre4,Hu Branda2,Jalloh Sarah Lartey5,Cox Rebecca Jane5,Ho Sammy6,Hoschler Katja6,Ollinger Thierry7,Trombetta Claudia Maria8,Engelhardt Othmar G.1,Caillet Catherine2ORCID

Affiliation:

1. National Institute for Biological Standards and Control, Potters Bar, United Kingdom

2. Sanofi Pasteur, Swiftwater, Pennsylvania, USA

3. Biomedical Primate Research Centre, Rijswijk, The Netherlands

4. Quinten, Paris, France

5. Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway

6. Public Health England, Colindale, United Kingdom

7. GSK, Wavre, Belgium

8. University of Siena, Department of Molecular and Developmental Medicine, Siena, Italy

Abstract

The hemagglutination inhibition (HAI) assay is the most commonly used serology assay to detect antibodies from influenza vaccination or influenza virus infection. This assay has been used for decades but requires improved standardization of procedures to provide meaningful data.

Funder

Innovative Medicines Initiative Joint Undertaking

European Union Seventh Framework Programme

European Federation of Pharmaceutical Industries and Associations

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3